scholarly journals The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor Protein

2004 ◽  
Vol 279 (38) ◽  
pp. 39421-39430 ◽  
Author(s):  
France Léveillé ◽  
Eric Blom ◽  
Annette L. Medhurst ◽  
Patrick Bier ◽  
El Houari Laghmani ◽  
...  
Cancer Cell ◽  
2005 ◽  
Vol 8 (3) ◽  
pp. 255-265 ◽  
Author(s):  
Rachel Litman ◽  
Min Peng ◽  
Zhe Jin ◽  
Fan Zhang ◽  
Junran Zhang ◽  
...  

2015 ◽  
Vol 5 (7) ◽  
pp. e323-e323 ◽  
Author(s):  
M T Voso ◽  
E Fabiani ◽  
Z Zang ◽  
L Fianchi ◽  
G Falconi ◽  
...  

Blood ◽  
1995 ◽  
Vol 86 (11) ◽  
pp. 4034-4038 ◽  
Author(s):  
PC Verlander ◽  
A Kaporis ◽  
Q Liu ◽  
Q Zhang ◽  
U Seligsohn ◽  
...  

Fanconi anemia (FA) is a genetically and phenotypically heterogeneous autosomal recessive disorder defined by a cellular hypersensitivity to DNA cross-linking agents. One of the FA genes, FAC, has been cloned and the genomic structure of the coding region has been characterized. We have developed amplification refractory mutation system (ARMS) assays for five known mutations in FAC, and have applied these assays to determine the carrier frequency of the IVS4 + 4 A-->T (IVS4) mutation in an Ashkenazi Jewish population. We tested 3,104 Jewish individuals, primarily of Ashkenazi descent, for the two most common FAC mutations, IVS4 and 322delG. Thirty-five IVS4 carriers were identified, for a carrier frequency of 1 in 89 (1.1%; 95% confidence interval 0.79% to 1.56%); no 322delG carriers were found. To determine if the IVS4 mutation was confined to the Ashkenazi Jewish population, we tested 563 Iraqi Jews for IVS4, and no carriers were found. Because the IVS4 mutation has only been found on chromosomes of Ashkenazi Jewish origin and is the only FAC mutation found on these chromosomes, we suggest that a founder effect is responsible for the high frequency of this mutation. With a carrier frequency greater than 1% and simple testing available, the IVS4 mutation merits inclusion in the battery of tests routinely provided to the Jewish population.


2001 ◽  
Vol 7 (2) ◽  
pp. 241-248 ◽  
Author(s):  
Cynthia Timmers ◽  
Toshiyasu Taniguchi ◽  
James Hejna ◽  
Carol Reifsteck ◽  
Lora Lucas ◽  
...  

2007 ◽  
Vol 6 (5) ◽  
pp. 654-660 ◽  
Author(s):  
Eike Gallmeier ◽  
Tomas Hucl ◽  
Eric S. Calhoun ◽  
Steven C. Cunningham ◽  
Fred Bunz ◽  
...  

2015 ◽  
Vol 26 (2) ◽  
pp. 114-126 ◽  
Author(s):  
Mark J. Osborn ◽  
Richard Gabriel ◽  
Beau R. Webber ◽  
Anthony P. DeFeo ◽  
Amber N. McElroy ◽  
...  

2009 ◽  
Vol 11 (11) ◽  
pp. 1012-1019 ◽  
Author(s):  
Kittiphong Paiboonsukwong ◽  
Fumi Ohbayashi ◽  
Haruka Shiiba ◽  
Emi Aizawa ◽  
Takayuki Yamashita ◽  
...  

Blood ◽  
2001 ◽  
Vol 98 (5) ◽  
pp. 1392-1401 ◽  
Author(s):  
Qishen Pang ◽  
Tracy A. Christianson ◽  
Winifred Keeble ◽  
Jane Diaz ◽  
Gregory R. Faulkner ◽  
...  

The Fanconi anemia (FA) group C gene product (FANCC) functions to protect cells from cytotoxic and genotoxic effects of cross-linking agents. FANCC is also required for optimal activation of STAT1 in response to cytokine and growth factors and for suppressing cytokine-induced apoptosis by modulating the activity of double-stranded RNA-dependent protein kinase. Because not all FANCC mutations affect STAT1 activation, the hypothesis was considered that cross-linker resistance function of FANCC depends on structural elements that differ from those required for the cytokine signaling functions of FANCC. Structure-function studies were designed to test this notion. Six separate alanine-substituted mutations were generated in 3 highly conserved motifs of FANCC. All mutants complemented mitomycin C (MMC) hypersensitive phenotype of FA-C cells and corrected aberrant posttranslational activation of FANCD2 in FA-C mutant cells. However, 2 of the mutants, S249A and E251A, failed to correct defective STAT1 activation. FA-C lymphoblasts carrying these 2 mutants demonstrated a defect in recruitment of STAT1 to the interferon γ (IFN-γ) receptor and GST-fusion proteins bearing S249A and E251A mutations were less efficient binding partners for STAT1 in stimulated lymphoblasts. These same mutations failed to complement the characteristic hypersensitive apoptotic responses of FA-C cells to tumor necrosis factor-α (TNF-α) and IFN-γ. Cells bearing a naturally occurring FANCC mutation (322delG) that preserves this conserved region showed normal STAT1 activation but remained hypersensitive to MMC. The conclusion is that a central highly conserved domain of FANCC is required for functional interaction with STAT1 and that structural elements required for STAT1-related functions differ from those required for genotoxic responses to cross-linking agents. Preservation of signaling capacity of cells bearing the del322G mutation may account for the reduced severity and later onset of bone marrow failure associated with this mutation.


Sign in / Sign up

Export Citation Format

Share Document